Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.9724
+0.08679.79%
Post-market: 0.9534-0.0190-1.95%16:44 EDT
Volume:781.67K
Turnover:743.38K
Market Cap:123.57M
PE:-2.18
High:0.9800
Open:0.9000
Low:0.8900
Close:0.8857
52wk High:4.31
52wk Low:0.6200
Shares:127.08M
Float Shares:64.68M
Volume Ratio:1.31
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4464
EPS(LYR):-0.4673
ROE:-36.21%
ROA:-20.83%
PB:0.94
PE(LYR):-2.08

Loading ...

Undervalued Penny Stocks To Consider In August 2026

Simply Wall St.
·
Aug 25

Nautilus Biotechnology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Nautilus Biotechnology Posts First Revenue, Q2 Net Loss Narrows

Reuters
·
Jul 28

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 Operating Expenses USD 15.938 Million

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 EPS USD -0.11

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K

Benzinga Earnings
·
Jul 28

Nautilus Biotechnology Inc Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Jul 24

Nautilus Biotechnology And 2 Promising Penny Stocks To Consider

Simply Wall St.
·
Jul 11

Nautilus Biotechnology to Report Q2 Results, Host Conference Call

Reuters
·
Jul 08

Nautilus Biotechnology shareholders elect Class II directors Mallick, Nazem at annual meeting

Reuters
·
Jun 19

AH Equity Partners Bio II disposes of 5,000,000 Nautilus Biotechnology shares worth $11,750,000

Reuters
·
Jun 05

Guggenheim Remains a Buy on Nautilus Biotechnolgy (NAUT)

TIPRANKS
·
Apr 29

Nautilus Biotechnology announces annual shareholder meeting webcast

Reuters
·
Apr 29

Nautilus Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 28

BRIEF-Nautilus Biotechnology Q1 EPS USD -0.12

Reuters
·
Apr 28

Nautilus Biotechnology Q1 Operating Expenses USD 16.124 Million

THOMSON REUTERS
·
Apr 28

Press Release: Nautilus Biotechnology Reports First Quarter 2026 Financial Results

Dow Jones
·
Apr 28

Nautilus Biotechnology Q1 FY26 net loss narrows to $14.7 million; operating expenses fall 14% to $16.1 million

Reuters
·
Apr 28

Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Benzinga Earnings
·
Apr 28